China Golden Classic Group Limited (8281.HK)
HKD 0.11
(10.0%)
HKD 0.11
(10.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 348.56 Million CNY | -4.28% |
| 2022 | 364.14 Million CNY | 3.15% |
| 2021 | 353.01 Million CNY | -1.7% |
| 2020 | 359.12 Million CNY | -4.68% |
| 2019 | 376.73 Million CNY | 3.38% |
| 2018 | 364.42 Million CNY | 5.48% |
| 2017 | 345.48 Million CNY | 3.95% |
| 2016 | 332.36 Million CNY | 36.2% |
| 2015 | 244.02 Million CNY | 11.78% |
| 2014 | 218.3 Million CNY | 29.45% |
| 2013 | 168.63 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 304.5 Million CNY | 0.0% |
| 2024 Q1 | 304.5 Million CNY | -12.64% |
| 2023 Q2 | 329.9 Million CNY | 0.0% |
| 2023 Q4 | 348.56 Million CNY | 0.0% |
| 2023 Q3 | - CNY | -100.0% |
| 2023 FY | 348.56 Million CNY | -4.28% |
| 2023 Q1 | - CNY | -100.0% |
| 2022 Q4 | 364.14 Million CNY | 0.0% |
| 2022 Q2 | 308.57 Million CNY | 0.0% |
| 2022 FY | 364.14 Million CNY | 3.15% |
| 2022 Q3 | - CNY | -100.0% |
| 2021 FY | 353.01 Million CNY | -1.7% |
| 2021 Q2 | 325.83 Million CNY | 0.0% |
| 2021 Q4 | 353.01 Million CNY | 0.0% |
| 2020 Q2 | 362.8 Million CNY | 0.0% |
| 2020 Q4 | 359.12 Million CNY | 0.0% |
| 2020 FY | 359.12 Million CNY | -4.68% |
| 2019 Q2 | 349.96 Million CNY | 0.0% |
| 2019 FY | 376.73 Million CNY | 3.38% |
| 2019 Q4 | 376.73 Million CNY | 0.0% |
| 2018 Q4 | 364.42 Million CNY | 0.0% |
| 2018 FY | 364.42 Million CNY | 5.48% |
| 2018 Q2 | 304.85 Million CNY | 0.0% |
| 2017 FY | 345.48 Million CNY | 3.95% |
| 2017 Q2 | 294.75 Million CNY | 0.0% |
| 2017 Q4 | 345.48 Million CNY | 0.0% |
| 2016 FY | 332.36 Million CNY | 36.2% |
| 2016 Q2 | 249.56 Million CNY | 0.0% |
| 2016 Q4 | 332.36 Million CNY | 0.0% |
| 2015 Q4 | 244.02 Million CNY | 0.0% |
| 2015 FY | 244.02 Million CNY | 11.78% |
| 2014 FY | 218.3 Million CNY | 29.45% |
| 2013 FY | 168.63 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 882.58 Million HKD | 60.506% |
| Innovative Pharmaceutical Biotech Limited | 1.38 Billion HKD | 74.797% |
| China Overseas Nuoxin International Holdings Limited | 149.17 Million HKD | -133.654% |
| Prosperous Future Holdings Limited | 810.79 Million HKD | 57.01% |
| Huasheng International Holding Limited | 1.63 Billion HKD | 78.694% |
| Fourace Industries Group Holdings Limited | 475.91 Million HKD | 26.76% |
| Evergreen Products Group Limited | 1.63 Billion HKD | 78.636% |
| EC Healthcare | 5.37 Billion HKD | 93.513% |
| Ming Fai International Holdings Limited | 1.96 Billion HKD | 82.263% |
| Blue Moon Group Holdings Limited | 12.05 Billion HKD | 97.108% |
| SuperRobotics Holdings Limited | 27.55 Million HKD | -1165.018% |
| Takbo Group Holdings Limited | 279.77 Million HKD | -24.587% |
| Hyfusin Group Holdings Limited | 686.91 Million HKD | 49.257% |